PV: Clinical Use of Hydroxyurea
Ruben Mesa, MD, describes the use of hydroxyurea and how to determine whether a patient with polycythemia vera is uncontrolled on or intolerant to hydroxyurea, as well as the options for patients at that point.
▶︎
Managing ET - Dr. Laura Michaelis
▶︎
CALQUENCE® (acalabrutinib) LY-004, Including 3-Year Follow-Up Data — Dr Phillips, MD
▶︎
Anemia? Maybe It’s Due To Low Iron
▶︎
What is the Current Standard of Care in Treating Polycythemia Vera (PV)?
▶︎
CMML - Diagnosis & Treatment :a presentation by consultant haematologist Dr. Daniel Wiseman
▶︎
How I Got Through Cancer Treatment & Side Effects (Myelofibrosis) | Mary’s Story | The Patient Story
▶︎
AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎
Taking Amlodipine, Losartan, or Lisinopril for Blood Pressure? Here's What Many Seniors Don't Know
▶︎
Doctor Gets MS, Goes From Wheelchair to Biking 18 Miles in One Year
▶︎
CLL Treatment EXPLAINED!
▶︎
5 Things That Surprise People Most About Hip Replacement
▶︎
Latest on Current Treatments for Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia
▶︎
الهيدروكسي يوريا و مرض فقر الدم المنجلي
▶︎
Hydroxyurea in Sickle Cell Disease
▶︎
Leukemias: Pathology review
▶︎
Sandra Navidi: „Billionär Elon Musk ist gefährlich“
▶︎
Challenges in the treatment and management of ET and the need to improve therapeutic approaches
▶︎
I Finally Understood Why My Patients Kept Getting Sick
▶︎
Sickle Cell Disease “Part 1” Intro
▶︎